Literature DB >> 20836706

Naturally occurring polymorphisms and primary drug resistance profile among antiretroviral-naive individuals in Bangalore, India.

Ujjwal Neogi1, B S Prarthana, Soham Gupta, George D'souza, Ayesha De Costa, Vijesh Sreedhar Kuttiatt, Karthika Arumugam, Anita Shet.   

Abstract

Although India has a large burden of HIV infection, good access to first-line antiretroviral therapy is widely available. However, understanding HIV resistance-associated mutations and polymorphisms is critical for continued success. The RT region of the HIV-1 pol gene was studied among 21 ART-naive HIV-1-infected individuals from South India. In addition, 421 published Indian HIV-1 subtype C sequences were analyzed for time trends in polymorphism frequency. Among primary isolates, all HIV-1 isolates were subtype C, and drug-resistant mutations were identified among two (9.56%) subjects. Mutations included E138A (etravirine resistance associated) and L210LS (thymidine analog mutation). The overall frequency of specific polymorphisms was similar to frequencies reported from different regions of India. Novel mutations were observed at positions Q23P/H and A129AG among isolates from our clinical cohort. Over a span of 10 years, the median polymorphism frequency among ART-naive subjects has remained unchanged, suggesting the slow evolution of HIV-1 subtype C in India.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20836706     DOI: 10.1089/aid.2010.0092

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

1.  Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India.

Authors:  Maria L Ekstrand; Anita Shet; Sara Chandy; Girija Singh; Ranjani Shamsundar; Vidya Madhavan; Shanmugam Saravanan; Elsa Heylen; Nagalingeswaran Kumarasamy
Journal:  Int Health       Date:  2011-03       Impact factor: 2.473

2.  Genetic characterization of HIV type 1 Tat exon 1 from a southern Indian clinical cohort: identification of unique epidemiological signature residues.

Authors:  Ujjwal Neogi; Soham Gupta; Pravat Nalini Sahoo; Anita Shet; Shwetha D Rao; Udaykumar Ranga; Vinayaka R Prasad
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-02       Impact factor: 2.205

Review 3.  Systematic review of HIV drug resistance in Southeast Asia.

Authors:  Andrew B Trotter; Steven Y Hong; Padmini Srikantiah; Iyanthi Abeyewickreme; Silvia Bertagnolio; Michael R Jordan
Journal:  AIDS Rev       Date:  2013 Jul-Sep       Impact factor: 2.500

4.  Global analysis of sequence diversity within HIV-1 subtypes across geographic regions.

Authors:  Austin Huang; Joseph W Hogan; Sorin Istrail; Allison Delong; David A Katzenstein; Rami Kantor
Journal:  Future Virol       Date:  2012-05       Impact factor: 1.831

5.  Selection of nonnucleoside reverse transcriptase inhibitor-associated mutations in HIV-1 subtype C: evidence of etravirine cross-resistance.

Authors:  Ujjwal Neogi; Anita Shet; Ranjani Shamsundar; Maria L Ekstrand
Journal:  AIDS       Date:  2011-05-15       Impact factor: 4.177

6.  Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India.

Authors:  Shanmugam Saravanan; Madhavan Vidya; Pachamuthu Balakrishnan; Rami Kantor; Sunil S Solomon; David Katzenstein; Nagalingeswaran Kumarasamy; Tokugha Yeptomi; Sathasivam Sivamalar; Samara Rifkin; Kenneth H Mayer; Suniti Solomon
Journal:  Clin Infect Dis       Date:  2012-02-09       Impact factor: 9.079

7.  Novel tetra-peptide insertion in Gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients.

Authors:  Ujjwal Neogi; Shwetha D Rao; Irene Bontell; Jens Verheyen; Vasudev R Rao; Sagar C Gore; Neelesh Soni; Anita Shet; Eugen Schülter; Maria L Ekstrand; Amogne Wondwossen; Rolf Kaiser; Mallur S Madhusudhan; Vinayaka R Prasad; Anders Sonnerborg
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

8.  Screening for and verification of novel mutations associated with drug resistance in the HIV type 1 subtype B(') in China.

Authors:  Hanping Li; Qingmao Geng; Wei Guo; Daomin Zhuang; Lin Li; Yongjian Liu; Zuoyi Bao; Siyang Liu; Jingyun Li
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

9.  Long-term efficacy of first line antiretroviral therapy in Indian HIV-1 infected patients: a longitudinal cohort study.

Authors:  Ujjwal Neogi; Elsa Heylen; Anita Shet; Sara Chandy; Ranjani Shamsunder; Anders Sönnerborg; Maria L Ekstrand
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

10.  High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naïve perinatally-infected children and adolescents with HIV-1 subtype C infection.

Authors:  Ujjwal Neogi; Pravat Nalini Sahoo; Ayesha De Costa; Anita Shet
Journal:  BMC Infect Dis       Date:  2012-11-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.